Literature DB >> 28749167

Diagnostic value of semi-quantitative and quantitative analysis of functional parameters in multiparametric MRI of the prostate.

Elke Hauth1, Daniela Halbritter2, Horst Jaeger1, Horst Hohmuth3, Meinrad Beer4.   

Abstract

OBJECTIVE: To determine the diagnostic value of semi-quantitative and quantitative parameters of three functional techniques in multiparametric (mp)-MRI of the prostate.
METHODS: Mp-MRI was performed in 110 patients with suspicion of prostate cancer (PCA) before transrectal ultrasound (TRUS)-guided core biopsy. Peak-enhancement, initial and post-initial enhancement, initial area under gadolinium curve, Ktrans (forward rate constant), Kep (efflux rate constant), Ve (extracellular volume), ADC (apparent diffusion coefficient) and MR spectroscopy ratio were obtained for malignant and benign lesions. For iAUGC, Ktrans, Kep and Ve we evaluated median, mean and the difference (Diff) between mean and median. For ADC we evaluated mean, median, Diff between mean and median, and min. In addition, we evaluated these parameters in dependence of Gleason score in PCA. Receiver operating characteristic analysis and area under curve (AUC) were determined.
RESULTS: ADC min and Kep Diff were the best predictors of malignancy in all lesions (AUC: 0.765). ADC min was the best predictor of malignancy for lesions in peripheral zone (PZ) (AUC: 0.7506) and Kep Diff was the best predictor of malignancy for lesions in transitional zone (AUC: 0.7514). Peak enhancement was the best parameter in differentiation of low-grade PCA with Gleason score 6 from high-grade PCA with Gleason score ≥ 7 (AUC: 0.7692).
CONCLUSION: ADC min can differentiate PCA from benign prostate lesions in PZ. Kep Diff could possibly improve prostate cancer detection in. Peak enhancement might be able to differentiate low grade from high-grade PCA. Semi-quantitative and quantitative parameters may be useful for the functional techniques in mp-MRI. Advances in knowledge: ADC min can differentiate PCA from benign prostate lesions in PZ. Peak enhancement might be able to differentiate low grade from high-grade PCA.

Entities:  

Mesh:

Year:  2017        PMID: 28749167      PMCID: PMC5853361          DOI: 10.1259/bjr.20170067

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  21 in total

Review 1.  Prostate cancer: multiparametric MR imaging for detection, localization, and staging.

Authors:  Caroline M A Hoeks; Jelle O Barentsz; Thomas Hambrock; Derya Yakar; Diederik M Somford; Stijn W T P J Heijmink; Tom W J Scheenen; Pieter C Vos; Henkjan Huisman; Inge M van Oort; J Alfred Witjes; Arend Heerschap; Jurgen J Fütterer
Journal:  Radiology       Date:  2011-10       Impact factor: 11.105

2.  Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts.

Authors:  P S Tofts; A G Kermode
Journal:  Magn Reson Med       Date:  1991-02       Impact factor: 4.668

3.  Quantitative 2- and 3-dimensional analysis of pharmacokinetic model-derived variables for breast lesions in dynamic, contrast-enhanced MR mammography.

Authors:  E A M Hauth; H J Jaeger; S Maderwald; A Muehler; R Kimmig; M Forsting
Journal:  Eur J Radiol       Date:  2007-07-19       Impact factor: 3.528

4.  Diffusion-weighted imaging of prostate cancer.

Authors:  Ryota Shimofusa; Hajime Fujimoto; Hajime Akamata; Ken Motoori; Seiji Yamamoto; Takuya Ueda; Hisao Ito
Journal:  J Comput Assist Tomogr       Date:  2005 Mar-Apr       Impact factor: 1.826

Review 5.  Dynamic contrast-enhanced MR imaging in the evaluation of patients with prostate cancer.

Authors:  Colm J McMahon; B Nicolas Bloch; Robert E Lenkinski; Neil M Rofsky
Journal:  Magn Reson Imaging Clin N Am       Date:  2009-05       Impact factor: 2.266

6.  Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer.

Authors:  Ferdinand A van Dorsten; Marinette van der Graaf; Marc R W Engelbrecht; Geert J L H van Leenders; Albert Verhofstad; Mark Rijpkema; Jean J M C H de la Rosette; Jelle O Barentsz; Arend Heerschap
Journal:  J Magn Reson Imaging       Date:  2004-08       Impact factor: 4.813

7.  Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.

Authors:  Iclal Ocak; Marcelino Bernardo; Greg Metzger; Tristan Barrett; Peter Pinto; Paul S Albert; Peter L Choyke
Journal:  AJR Am J Roentgenol       Date:  2007-10       Impact factor: 3.959

8.  Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score--a computer-aided diagnosis development study.

Authors:  Yahui Peng; Yulei Jiang; Cheng Yang; Jeremy Bancroft Brown; Tatjana Antic; Ila Sethi; Christine Schmid-Tannwald; Maryellen L Giger; Scott E Eggener; Aytekin Oto
Journal:  Radiology       Date:  2013-02-07       Impact factor: 11.105

9.  Multiparametric MRI of the prostate with three functional techniques in patients with PSA elevation before initial TRUS-guided biopsy.

Authors:  Elke Hauth; Horst Hohmuth; Corina Cozub-Poetica; Stefan Bernand; Meinrad Beer; Horst Jaeger
Journal:  Br J Radiol       Date:  2015-08-13       Impact factor: 3.039

10.  ESUR prostate MR guidelines 2012.

Authors:  Jelle O Barentsz; Jonathan Richenberg; Richard Clements; Peter Choyke; Sadhna Verma; Geert Villeirs; Olivier Rouviere; Vibeke Logager; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315

View more
  1 in total

1.  The utility of ADC parameters in the diagnosis of clinically significant prostate cancer by 3.0-Tesla diffusion-weighted magnetic resonance imaging.

Authors:  Aylin Altan Kus
Journal:  Pol J Radiol       Date:  2021-05-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.